Phenotypes associated with this allele
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mogtm1(cre)Gkl mutation
(1 available);
any
Mog mutation
(58 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
immune system
|
|
• between 15% and 20% of mice develop spontaneous EAE
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igh-Jtm1Aigl mutation
(0 available);
any
Igh-J mutation
(13 available)
Mogtm1Dpd mutation
(0 available);
any
Mog mutation
(58 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
behavior/neurological
|
|
• disease started between 7 and 10 weeks of age, with classical paralytic EAE signs
|
muscle
|
|
• in a minority of cases, with a spastic component
|
nervous system
|
|
• inflammatory infiltrates in the trigeminal ganglia, spinal ganglia, spinal roots despite the absence of MOG within these tissues
|
|
|
• inflammatory infiltrates in the peripheral nervous system despite the absence of MOG within these tissues
|
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in optic nerve
|
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in the spinal cord
|
|
|
• within the spinal cord and optic nerve
|
vision/eye
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in optic nerve
|
immune system
|
|
• 15% of the mice develop spontaneous EAE
|
|
|
• inflammatory infiltrates in the trigeminal ganglia, spinal ganglia, spinal roots despite the absence of MOG within these tissues
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igh-Jtm1Aigl mutation
(0 available);
any
Igh-J mutation
(13 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
behavior/neurological
|
|
• disease started between 7 and 10 weeks of age, with classical paralytic EAE signs
|
immune system
|
|
• fifty percent spontaneously develop opticospinal myelitis
|
|
|
• inflammatory infiltrates in the trigeminal ganglia, spinal ganglia, spinal roots despite the absence of MOG within these tissues
|
muscle
|
|
• in a minority of cases, with a spastic component
|
nervous system
|
|
• inflammatory infiltrates in the trigeminal ganglia, spinal ganglia, spinal roots despite the absence of MOG within these tissues
|
|
|
• inflammatory infiltrates in the peripheral nervous system despite the absence of MOG within these tissues
|
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in optic nerve
|
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in the spinal cord
|
|
|
• within the spinal cord and optic nerve
|
vision/eye
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in optic nerve
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdcd1tm1Hon mutation
(6 available);
any
Pdcd1 mutation
(97 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
immune system
|
|
• in conjunction with anti-CTLA-4 antibody treatment, mice exhibit reduced paralysis induced by experimental autoimmune encephalomyelitis (EAE) compared to wild type mice
• however, adoptive transfer of Gt(ROSA)26Sortm2Awai Cd19tm1(cre)Cgn double heterozygous B cells increases paralysis induced by EAE despite treatment with anti-CTLA-4 antibodies compared to wild-type mice receiving Gt(ROSA)26Sortm2Awai Cd19tm1(cre)Cgn double heterozygous B cells
|
immune system
|
|
• mice exhibit accelerated onset and succumb to complete hindlimb paralysis faster than control mice
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mogtm1Dpd mutation
(0 available);
any
Mog mutation
(58 available)
Rag2tm1Cgn mutation
(2 available);
any
Rag2 mutation
(117 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
immune system
|
|
• spontaneous EAE develops in two out of six mice
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mogtm1Dpd mutation
(0 available);
any
Mog mutation
(58 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
behavior/neurological
|
|
• disease started between 7 and 10 weeks of age, with classical paralytic EAE signs
|
immune system
|
|
• between 15% and 20% of mice develop spontaneous EAE
|
|
|
• inflammatory infiltrates in the trigeminal ganglia, spinal ganglia, spinal roots despite the absence of MOG within these tissues
|
muscle
|
|
• in a minority of cases, with a spastic component
|
nervous system
|
|
• inflammatory infiltrates in the trigeminal ganglia, spinal ganglia, spinal roots despite the absence of MOG within these tissues
|
|
|
• inflammatory infiltrates in the peripheral nervous system despite the absence of MOG within these tissues
|
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in optic nerve
|
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in the spinal cord
|
|
|
• within the spinal cord and optic nerve
|
vision/eye
|
|
• lesions consisting of lymphocytic infiltration, demyelation and axonal damage in optic nerve
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
Vsirtm1Lex mutation
(2 available);
any
Vsir mutation
(24 available)
|
|
|
immune system
|
|
• mice exhibit accelerated onset compared with control mice
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
H2-T23tm2Cant mutation
(0 available);
any
H2-T23 mutation
(35 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
immune system
|
|
• CD4 T cells are highly susceptible to dose-dependent suppression by CD8 T regulatory cells in vitro
• this suppression is dependent on Fas ligand being expressed by the CD8 T regulatory cell
|
|
|
• transfer of CD4 T cells into Rag2-/- Prf1-/- hosts initiates a progressive and lethal form of EAE that results in death from fulminant disease within 14?16 days after transfer
• co-transfer of CD8 T regulatory cells with mutant CD4 T cells prevents disease where as co-transfer of CD8 T regulatory cells with transgenic CD4 T cells not carrying the H2-T23 mutation fails to prevent disease
|
hematopoietic system
|
|
• CD4 T cells are highly susceptible to dose-dependent suppression by CD8 T regulatory cells in vitro
• this suppression is dependent on Fas ligand being expressed by the CD8 T regulatory cell
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
H2-T23tm3Cant mutation
(0 available);
any
H2-T23 mutation
(35 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
immune system
|
|
• CD4 T cells are fully resistant to suppression by CD8 T regulatory cells in vitro as measured by proliferation and IL-2 secretion
|
hematopoietic system
|
|
• CD4 T cells are fully resistant to suppression by CD8 T regulatory cells in vitro as measured by proliferation and IL-2 secretion
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
Tigittm1Sdl mutation
(0 available);
any
Tigit mutation
(31 available)
|
|
|
immune system
|
|
• unlike Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd5tm1.1Chra mutation
(0 available);
any
Cd5 mutation
(36 available)
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
immune system
|
|
• in CD4+ T cells stimulated with anti-CD3
|
|
|
• under nonpolarizing conditions
|
|
|
• in CD4+ T cells under nonpolarizing conditions
|
|
|
• in CD4+ T cells stimulated with MOG35-55 compared with cells from wild-type control but not as much as in cells from Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
• in CD4+ T cells stimulated with MOG35-55 compared with cells from wild-type control but not as much as in cells from Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
• IL2 levels from CD4+ T cells stimulated with MOG35-55 do not persist as long as in cells from wild-type mice
|
|
|
• in CD4+ T cells stimulated with MOG35-55 compared with cells from wild-type control but not as much as in cells from Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
hematopoietic system
|
|
• in CD4+ T cells stimulated with anti-CD3
|
|
|
• under nonpolarizing conditions
|
cellular
|
|
• in CD4+ T cells stimulated with anti-CD3
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
immune system
|
|
• under Th17 polarizing conditions
|
|
|
• of CD4+ T cells stimulated with anti-CD3
|
|
|
• in CD4+ T cells stimulated with MOG35-55, rested then restimulated with MOG35-55 compared with cells from wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
• under nonpolarizing conditions, Th1 cells are reduced 50% compared to in wild-type but are 3-fold higher than in Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
• in T cells cultures stimulated with MOG35-55
|
|
|
• 50% under Th17 polarizing conditions compared with wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
• in T cells cultures stimulated with MOG35-55
|
|
|
• under Th2 polarizing conditions compared with wild-type controls and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
• in CD4+ T cells under nonpolarizing conditions
|
|
|
• in CD4+ T cells stimulated with MOG35-55 compared with cells from wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
• IL10 levels in T cells stimulated with MOG35-55 rise and contract unlike in cells from wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice where levels continue to rise
|
|
|
• in CD4+ T cells stimulated with MOG35-55 compared with cells from wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
• IL2 levels from T cells stimulated with MOG35-55 do not increase beyond day 1unlike in cells from wild-type control
|
|
|
• in CD4+ T cells stimulated with MOG35-55 compared with cells from wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
cellular
|
|
• under Th17 polarizing conditions
|
|
|
• of CD4+ T cells stimulated with anti-CD3
|
|
|
• in CD4+ T cells stimulated with MOG35-55, rested then restimulated with MOG35-55 compared with cells from wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
hematopoietic system
|
|
• under Th17 polarizing conditions
|
|
|
• of CD4+ T cells stimulated with anti-CD3
|
|
|
• in CD4+ T cells stimulated with MOG35-55, rested then restimulated with MOG35-55 compared with cells from wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
• under nonpolarizing conditions, Th1 cells are reduced 50% compared to in wild-type but are 3-fold higher than in Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
• in T cells cultures stimulated with MOG35-55
|
|
|
• 50% under Th17 polarizing conditions compared with wild-type control and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
• in T cells cultures stimulated with MOG35-55
|
|
|
• under Th2 polarizing conditions compared with wild-type controls and Cd5tm1Cgn/Cd5tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch mice
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
mortality/aging
|
|
• 40% of transgenic mice succumb to EAE compared to no non-transgenic littermates
|
nervous system
|
|
• 7/15 mice without EAE show typical myelinating/demyelinating lesions of optic neuritis
• mice with EAE show typical myelinating/demyelinating lesions of optic neuritis
• 55 and 78% of transgenic mice immunized with 100 and 10 ug of MOG 35-55 without PT, respectively, develop optic nerve lesions
|
|
|
• mice with or without EAE that display optic neuritis have myelinating/demyelinating lesions consisting of subpial and endoneurial mononuclear cell infiltrates with demyelination indicated by presence of foamy macrophages
|
|
|
• mice with optic neuritis have varying degrees of axonal injury and loss
|
|
|
• CNS tissues show myelin loss
|
vision/eye
|
|
• mice without EAE develop superficial inflammation around the eyelids; this is unilateral and not observed in wild-type littermates during up to 1 year observation
|
|
|
• superficial eye lesions in mice without EAE are often associated with progressive atrophy of the eye
• 67% of mutants show these eye lesions compared to no wild-type
|
|
|
• mice without EAE show eyelid inflammation and eyelid swelling; this is unilateral and not observed in wild-type littermates during up to 1 year observation
|
|
|
• mice with or without EAE that display optic neuritis have myelinating/demyelinating lesions consisting of subpial and endoneurial mononuclear cell infiltrates with demyelination indicated by presence of foamy macrophages
|
immune system
|
|
• CD4/CD8 single positive ratio in thymus of transgenic mice is biased toward CD4+ compartment
• analysis shows a skewing toward CD4+ T cells in spleens as well
|
|
|
• spleen cells from naive mice produce high levels of IFN gamma in response to MOG 35-55
|
|
|
• 4% (3/72) of mice develop spontaneous EAE, indicated initially by a limp tail, followed by hindlimb paralysis between 2.5 and 5 months of age
• 55 and 78% of mice immunized with 100 and 10 ug of MOG 35-55 without PT, respectively, develop optic nerve lesions
• mice with disease have typical myelinating/demyelinating lesions
|
|
|
• transgenic mice immunized with MOG 35-55 + pertussis toxin (PT) develop more severe EAE than non-transgenic littermates, with earlier onset and greater clinical scores; 50% of mice develop associated optic neuritis also
• injection of PT alone induces clinical EAE in 39% and histological EAE in 56% of transgenics compared to no non-transgenic mice; 80% of mice develop associated optic neuritis also
|
|
|
• 7/15 mice without EAE show typical myelinating/demyelinating lesions of optic neuritis
• mice with EAE show typical myelinating/demyelinating lesions of optic neuritis
• 55 and 78% of transgenic mice immunized with 100 and 10 ug of MOG 35-55 without PT, respectively, develop optic nerve lesions
|
|
|
• mice without EAE develop superficial inflammation around the eyelids; this is unilateral and not observed in wild-type littermates during up to 1 year observation
|
hematopoietic system
|
|
• CD4/CD8 single positive ratio in thymus of transgenic mice is biased toward CD4+ compartment
• analysis shows a skewing toward CD4+ T cells in spleens as well
|
cellular
|
|
• spleen cells from naive mice show increased proliferative response to myelin oligodendrocyte protein peptide 35-55 (MOG 35-55) compared to wild-type mice
|
homeostasis/metabolism
craniofacial
|
|
• mice without EAE show eyelid inflammation and eyelid swelling; this is unilateral and not observed in wild-type littermates during up to 1 year observation
|
growth/size/body
|
|
• mice without EAE show eyelid inflammation and eyelid swelling; this is unilateral and not observed in wild-type littermates during up to 1 year observation
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Tcra2D2,Tcrb2D2)1Kuch mutation
(1 available)
|
|
|
immune system
|
|
• T cells incubated with LPS-stimulated CD11c+ dendritic cells with IL-23 in the presence of MOG peptide and neutralizing antibodies against IFN-gamma and IL-4 plus either IL-25 or IL-13 antibodies produce less IL-17 than with both IL-25 and IL-13 antibodies or without either
|
Analysis Tools